nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketoconazole—P-Glycoprotein Inhibitors—Vemurafenib—skin cancer	0.651	1	CiPCiCtD
Ketoconazole—CYP1A2—Imiquimod—skin cancer	0.0219	0.0845	CbGbCtD
Ketoconazole—CYP1B1—Docetaxel—skin cancer	0.021	0.0811	CbGbCtD
Ketoconazole—CYP1A1—Dacarbazine—skin cancer	0.0206	0.0795	CbGbCtD
Ketoconazole—CYP2C8—Vismodegib—skin cancer	0.0196	0.0757	CbGbCtD
Ketoconazole—CYP2C19—Vismodegib—skin cancer	0.0165	0.0635	CbGbCtD
Ketoconazole—CYP2A6—Fluorouracil—skin cancer	0.0141	0.0545	CbGbCtD
Ketoconazole—CYP2C9—Vismodegib—skin cancer	0.0137	0.0528	CbGbCtD
Ketoconazole—ABCB1—Vismodegib—skin cancer	0.0133	0.0512	CbGbCtD
Ketoconazole—CYP1A2—Vemurafenib—skin cancer	0.012	0.0463	CbGbCtD
Ketoconazole—CYP3A4—Temozolomide—skin cancer	0.0115	0.0443	CbGbCtD
Ketoconazole—CYP3A4—Imiquimod—skin cancer	0.0115	0.0443	CbGbCtD
Ketoconazole—CYP2D6—Vemurafenib—skin cancer	0.0099	0.0382	CbGbCtD
Ketoconazole—CYP1A2—Dacarbazine—skin cancer	0.00921	0.0355	CbGbCtD
Ketoconazole—CYP3A4—Vismodegib—skin cancer	0.00797	0.0307	CbGbCtD
Ketoconazole—CYP3A7-CYP3A51P—Docetaxel—skin cancer	0.00739	0.0285	CbGbCtD
Ketoconazole—CYP3A7—Docetaxel—skin cancer	0.00739	0.0285	CbGbCtD
Ketoconazole—ABCB1—Dactinomycin—skin cancer	0.00698	0.0269	CbGbCtD
Ketoconazole—CYP2C8—Fluorouracil—skin cancer	0.00698	0.0269	CbGbCtD
Ketoconazole—CYP3A4—Vemurafenib—skin cancer	0.0063	0.0243	CbGbCtD
Ketoconazole—CYP3A5—Docetaxel—skin cancer	0.00554	0.0213	CbGbCtD
Ketoconazole—CYP1A2—Fluorouracil—skin cancer	0.0054	0.0208	CbGbCtD
Ketoconazole—CYP2C9—Fluorouracil—skin cancer	0.00487	0.0187	CbGbCtD
Ketoconazole—ABCB1—Docetaxel—skin cancer	0.00361	0.0139	CbGbCtD
Ketoconazole—AR—scrotum—skin cancer	0.00254	0.173	CbGeAlD
Ketoconazole—CYP3A4—Docetaxel—skin cancer	0.00216	0.00832	CbGbCtD
Ketoconazole—AR—penis—skin cancer	0.00115	0.0781	CbGeAlD
Ketoconazole—CYP26A1—female reproductive system—skin cancer	0.000719	0.0491	CbGeAlD
Ketoconazole—CYP27B1—female reproductive system—skin cancer	0.000641	0.0437	CbGeAlD
Ketoconazole—CYP1B1—hair follicle—skin cancer	0.000465	0.0317	CbGeAlD
Ketoconazole—CYP1A1—skin epidermis—skin cancer	0.000461	0.0314	CbGeAlD
Ketoconazole—CYP24A1—female reproductive system—skin cancer	0.000444	0.0303	CbGeAlD
Ketoconazole—CYP17A1—connective tissue—skin cancer	0.000396	0.027	CbGeAlD
Ketoconazole—CYP11A1—connective tissue—skin cancer	0.000368	0.0251	CbGeAlD
Ketoconazole—AR—nipple—skin cancer	0.000299	0.0204	CbGeAlD
Ketoconazole—CYP17A1—female reproductive system—skin cancer	0.000279	0.019	CbGeAlD
Ketoconazole—CYP11B2—lymph node—skin cancer	0.000267	0.0182	CbGeAlD
Ketoconazole—CYP11A1—female reproductive system—skin cancer	0.00026	0.0177	CbGeAlD
Ketoconazole—CYP19A1—connective tissue—skin cancer	0.000239	0.0163	CbGeAlD
Ketoconazole—CYP17A1—head—skin cancer	0.000233	0.0159	CbGeAlD
Ketoconazole—CYP1A2—nipple—skin cancer	0.000226	0.0154	CbGeAlD
Ketoconazole—CYP1B1—connective tissue—skin cancer	0.000224	0.0153	CbGeAlD
Ketoconazole—CYP1A1—nipple—skin cancer	0.000223	0.0152	CbGeAlD
Ketoconazole—CYP11A1—head—skin cancer	0.000217	0.0148	CbGeAlD
Ketoconazole—AR—connective tissue—skin cancer	0.000212	0.0144	CbGeAlD
Ketoconazole—Malaise—Imiquimod—skin cancer	0.000206	0.00273	CcSEcCtD
Ketoconazole—Breast disorder—Temozolomide—skin cancer	0.000205	0.00273	CcSEcCtD
Ketoconazole—CYP1B1—skin of body—skin cancer	0.000202	0.0138	CbGeAlD
Ketoconazole—AR—epithelium—skin cancer	0.000201	0.0137	CbGeAlD
Ketoconazole—Musculoskeletal discomfort—Vemurafenib—skin cancer	0.000199	0.00264	CcSEcCtD
Ketoconazole—Myalgia—Imiquimod—skin cancer	0.000194	0.00258	CcSEcCtD
Ketoconazole—Arthralgia—Imiquimod—skin cancer	0.000194	0.00258	CcSEcCtD
Ketoconazole—Unspecified disorder of skin and subcutaneous tissue—Imiquimod—skin cancer	0.000193	0.00256	CcSEcCtD
Ketoconazole—Discomfort—Imiquimod—skin cancer	0.000192	0.00255	CcSEcCtD
Ketoconazole—Dry skin—Fluorouracil—skin cancer	0.000192	0.00255	CcSEcCtD
Ketoconazole—AR—skin of body—skin cancer	0.000191	0.013	CbGeAlD
Ketoconazole—Dry mouth—Imiquimod—skin cancer	0.00019	0.00252	CcSEcCtD
Ketoconazole—Decreased appetite—Vemurafenib—skin cancer	0.00019	0.00252	CcSEcCtD
Ketoconazole—Gastrointestinal disorder—Vemurafenib—skin cancer	0.000189	0.0025	CcSEcCtD
Ketoconazole—Fatigue—Vemurafenib—skin cancer	0.000188	0.0025	CcSEcCtD
Ketoconazole—Constipation—Vemurafenib—skin cancer	0.000187	0.00248	CcSEcCtD
Ketoconazole—Nervous system disorder—Imiquimod—skin cancer	0.000183	0.00243	CcSEcCtD
Ketoconazole—Skin disorder—Imiquimod—skin cancer	0.000181	0.0024	CcSEcCtD
Ketoconazole—Erectile dysfunction—Temozolomide—skin cancer	0.000181	0.0024	CcSEcCtD
Ketoconazole—Photosensitivity reaction—Temozolomide—skin cancer	0.000179	0.00238	CcSEcCtD
Ketoconazole—Anorexia—Imiquimod—skin cancer	0.000178	0.00236	CcSEcCtD
Ketoconazole—AR—mammalian vulva—skin cancer	0.000174	0.0119	CbGeAlD
Ketoconazole—Hepatitis—Dactinomycin—skin cancer	0.000174	0.00231	CcSEcCtD
Ketoconazole—Body temperature increased—Vemurafenib—skin cancer	0.000173	0.00229	CcSEcCtD
Ketoconazole—Swelling—Docetaxel—skin cancer	0.000171	0.00227	CcSEcCtD
Ketoconazole—Musculoskeletal discomfort—Imiquimod—skin cancer	0.00017	0.00225	CcSEcCtD
Ketoconazole—CYP19A1—female reproductive system—skin cancer	0.000169	0.0115	CbGeAlD
Ketoconazole—Insomnia—Imiquimod—skin cancer	0.000168	0.00224	CcSEcCtD
Ketoconazole—Hepatic failure—Docetaxel—skin cancer	0.000168	0.00223	CcSEcCtD
Ketoconazole—Paraesthesia—Imiquimod—skin cancer	0.000167	0.00222	CcSEcCtD
Ketoconazole—Chills—Bleomycin—skin cancer	0.000167	0.00222	CcSEcCtD
Ketoconazole—Somnolence—Imiquimod—skin cancer	0.000166	0.0022	CcSEcCtD
Ketoconazole—Hepatobiliary disease—Temozolomide—skin cancer	0.000166	0.0022	CcSEcCtD
Ketoconazole—Photosensitivity reaction—Fluorouracil—skin cancer	0.000165	0.00219	CcSEcCtD
Ketoconazole—Alopecia—Bleomycin—skin cancer	0.000165	0.00219	CcSEcCtD
Ketoconazole—Erythema multiforme—Dactinomycin—skin cancer	0.000164	0.00218	CcSEcCtD
Ketoconazole—Dyspepsia—Imiquimod—skin cancer	0.000164	0.00218	CcSEcCtD
Ketoconazole—CYP1B1—lymphoid tissue—skin cancer	0.000164	0.0112	CbGeAlD
Ketoconazole—CYP17A1—lymph node—skin cancer	0.000163	0.0111	CbGeAlD
Ketoconazole—Erythema—Bleomycin—skin cancer	0.000162	0.00215	CcSEcCtD
Ketoconazole—Decreased appetite—Imiquimod—skin cancer	0.000162	0.00215	CcSEcCtD
Ketoconazole—Hot flush—Docetaxel—skin cancer	0.000161	0.00214	CcSEcCtD
Ketoconazole—Hypersensitivity—Vemurafenib—skin cancer	0.000161	0.00214	CcSEcCtD
Ketoconazole—Gastrointestinal disorder—Imiquimod—skin cancer	0.000161	0.00214	CcSEcCtD
Ketoconazole—Fatigue—Imiquimod—skin cancer	0.000161	0.00213	CcSEcCtD
Ketoconazole—ABCB1—blood vessel—skin cancer	0.00016	0.0109	CbGeAlD
Ketoconazole—Menopausal symptoms—Docetaxel—skin cancer	0.00016	0.00213	CcSEcCtD
Ketoconazole—Pain—Imiquimod—skin cancer	0.000159	0.00212	CcSEcCtD
Ketoconazole—CYP1B1—female reproductive system—skin cancer	0.000158	0.0108	CbGeAlD
Ketoconazole—Hepatitis—Temozolomide—skin cancer	0.000157	0.00209	CcSEcCtD
Ketoconazole—Asthenia—Vemurafenib—skin cancer	0.000157	0.00208	CcSEcCtD
Ketoconazole—Chills—Dactinomycin—skin cancer	0.000156	0.00207	CcSEcCtD
Ketoconazole—AR—lymphoid tissue—skin cancer	0.000155	0.0106	CbGeAlD
Ketoconazole—Oedema peripheral—Temozolomide—skin cancer	0.000155	0.00206	CcSEcCtD
Ketoconazole—Pruritus—Vemurafenib—skin cancer	0.000155	0.00205	CcSEcCtD
Ketoconazole—Connective tissue disorder—Temozolomide—skin cancer	0.000154	0.00205	CcSEcCtD
Ketoconazole—Alopecia—Dactinomycin—skin cancer	0.000154	0.00204	CcSEcCtD
Ketoconazole—Feeling abnormal—Imiquimod—skin cancer	0.000154	0.00204	CcSEcCtD
Ketoconazole—Gastrointestinal pain—Imiquimod—skin cancer	0.000152	0.00202	CcSEcCtD
Ketoconazole—Epistaxis—Fluorouracil—skin cancer	0.000152	0.00202	CcSEcCtD
Ketoconazole—CYP11A1—lymph node—skin cancer	0.000152	0.0104	CbGeAlD
Ketoconazole—Erythema—Dactinomycin—skin cancer	0.000151	0.00201	CcSEcCtD
Ketoconazole—Ill-defined disorder—Bleomycin—skin cancer	0.00015	0.002	CcSEcCtD
Ketoconazole—CYP1A1—epithelium—skin cancer	0.00015	0.0102	CbGeAlD
Ketoconazole—Diarrhoea—Vemurafenib—skin cancer	0.000149	0.00198	CcSEcCtD
Ketoconazole—AR—female reproductive system—skin cancer	0.000149	0.0102	CbGeAlD
Ketoconazole—Erythema multiforme—Temozolomide—skin cancer	0.000149	0.00197	CcSEcCtD
Ketoconazole—Urticaria—Imiquimod—skin cancer	0.000148	0.00196	CcSEcCtD
Ketoconazole—Abdominal pain—Imiquimod—skin cancer	0.000147	0.00196	CcSEcCtD
Ketoconazole—Body temperature increased—Imiquimod—skin cancer	0.000147	0.00196	CcSEcCtD
Ketoconazole—Eye disorder—Temozolomide—skin cancer	0.000147	0.00195	CcSEcCtD
Ketoconazole—Malaise—Bleomycin—skin cancer	0.000146	0.00194	CcSEcCtD
Ketoconazole—Leukopenia—Bleomycin—skin cancer	0.000145	0.00193	CcSEcCtD
Ketoconazole—Dizziness—Vemurafenib—skin cancer	0.000144	0.00192	CcSEcCtD
Ketoconazole—SLCO1A2—head—skin cancer	0.000144	0.00985	CbGeAlD
Ketoconazole—CYP1A1—skin of body—skin cancer	0.000143	0.00974	CbGeAlD
Ketoconazole—Angiopathy—Temozolomide—skin cancer	0.000143	0.00189	CcSEcCtD
Ketoconazole—Immune system disorder—Temozolomide—skin cancer	0.000142	0.00188	CcSEcCtD
Ketoconazole—Mediastinal disorder—Temozolomide—skin cancer	0.000142	0.00188	CcSEcCtD
Ketoconazole—Chills—Temozolomide—skin cancer	0.000141	0.00187	CcSEcCtD
Ketoconazole—CYP19A1—head—skin cancer	0.000141	0.00961	CbGeAlD
Ketoconazole—Ill-defined disorder—Dactinomycin—skin cancer	0.00014	0.00186	CcSEcCtD
Ketoconazole—Vomiting—Vemurafenib—skin cancer	0.000139	0.00184	CcSEcCtD
Ketoconazole—Alopecia—Temozolomide—skin cancer	0.000139	0.00184	CcSEcCtD
Ketoconazole—CYP2B6—skin of body—skin cancer	0.000139	0.00946	CbGeAlD
Ketoconazole—Dry skin—Docetaxel—skin cancer	0.000138	0.00184	CcSEcCtD
Ketoconazole—Myalgia—Bleomycin—skin cancer	0.000138	0.00183	CcSEcCtD
Ketoconazole—Abdominal pain upper—Docetaxel—skin cancer	0.000138	0.00183	CcSEcCtD
Ketoconazole—Orthostatic hypotension—Docetaxel—skin cancer	0.000138	0.00183	CcSEcCtD
Ketoconazole—Rash—Vemurafenib—skin cancer	0.000138	0.00183	CcSEcCtD
Ketoconazole—Mental disorder—Temozolomide—skin cancer	0.000138	0.00183	CcSEcCtD
Ketoconazole—Dermatitis—Vemurafenib—skin cancer	0.000138	0.00183	CcSEcCtD
Ketoconazole—Hypersensitivity—Imiquimod—skin cancer	0.000137	0.00182	CcSEcCtD
Ketoconazole—Headache—Vemurafenib—skin cancer	0.000137	0.00182	CcSEcCtD
Ketoconazole—Malnutrition—Temozolomide—skin cancer	0.000137	0.00182	CcSEcCtD
Ketoconazole—Erythema—Temozolomide—skin cancer	0.000137	0.00182	CcSEcCtD
Ketoconazole—Breast disorder—Docetaxel—skin cancer	0.000137	0.00181	CcSEcCtD
Ketoconazole—Discomfort—Bleomycin—skin cancer	0.000136	0.00181	CcSEcCtD
Ketoconazole—Malaise—Dactinomycin—skin cancer	0.000136	0.00181	CcSEcCtD
Ketoconazole—Leukopenia—Dactinomycin—skin cancer	0.000135	0.0018	CcSEcCtD
Ketoconazole—Dysgeusia—Temozolomide—skin cancer	0.000134	0.00178	CcSEcCtD
Ketoconazole—Asthenia—Imiquimod—skin cancer	0.000134	0.00177	CcSEcCtD
Ketoconazole—Anaphylactic shock—Bleomycin—skin cancer	0.000132	0.00176	CcSEcCtD
Ketoconazole—Pruritus—Imiquimod—skin cancer	0.000132	0.00175	CcSEcCtD
Ketoconazole—CYP1B1—head—skin cancer	0.000132	0.00899	CbGeAlD
Ketoconazole—CYP1A1—mammalian vulva—skin cancer	0.00013	0.00888	CbGeAlD
Ketoconazole—Nausea—Vemurafenib—skin cancer	0.00013	0.00172	CcSEcCtD
Ketoconazole—Thrombocytopenia—Bleomycin—skin cancer	0.00013	0.00172	CcSEcCtD
Ketoconazole—Arrhythmia—Fluorouracil—skin cancer	0.000129	0.00172	CcSEcCtD
Ketoconazole—Myalgia—Dactinomycin—skin cancer	0.000129	0.00171	CcSEcCtD
Ketoconazole—Alopecia—Fluorouracil—skin cancer	0.000128	0.0017	CcSEcCtD
Ketoconazole—Diarrhoea—Imiquimod—skin cancer	0.000127	0.00169	CcSEcCtD
Ketoconazole—Discomfort—Dactinomycin—skin cancer	0.000127	0.00169	CcSEcCtD
Ketoconazole—Ill-defined disorder—Temozolomide—skin cancer	0.000127	0.00169	CcSEcCtD
Ketoconazole—Anorexia—Bleomycin—skin cancer	0.000126	0.00167	CcSEcCtD
Ketoconazole—Erythema—Fluorouracil—skin cancer	0.000126	0.00167	CcSEcCtD
Ketoconazole—Angioedema—Temozolomide—skin cancer	0.000125	0.00166	CcSEcCtD
Ketoconazole—AR—head—skin cancer	0.000125	0.00851	CbGeAlD
Ketoconazole—Malaise—Temozolomide—skin cancer	0.000123	0.00164	CcSEcCtD
Ketoconazole—Dizziness—Imiquimod—skin cancer	0.000123	0.00164	CcSEcCtD
Ketoconazole—Leukopenia—Temozolomide—skin cancer	0.000122	0.00163	CcSEcCtD
Ketoconazole—Thrombocytopenia—Dactinomycin—skin cancer	0.000121	0.0016	CcSEcCtD
Ketoconazole—CYP2C8—female reproductive system—skin cancer	0.000121	0.00824	CbGeAlD
Ketoconazole—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000121	0.0016	CcSEcCtD
Ketoconazole—Paraesthesia—Bleomycin—skin cancer	0.000119	0.00158	CcSEcCtD
Ketoconazole—Vomiting—Imiquimod—skin cancer	0.000118	0.00157	CcSEcCtD
Ketoconazole—Anorexia—Dactinomycin—skin cancer	0.000118	0.00156	CcSEcCtD
Ketoconazole—Rash—Imiquimod—skin cancer	0.000117	0.00156	CcSEcCtD
Ketoconazole—Dermatitis—Imiquimod—skin cancer	0.000117	0.00156	CcSEcCtD
Ketoconazole—Headache—Imiquimod—skin cancer	0.000117	0.00155	CcSEcCtD
Ketoconazole—Arthralgia—Temozolomide—skin cancer	0.000116	0.00155	CcSEcCtD
Ketoconazole—Myalgia—Temozolomide—skin cancer	0.000116	0.00155	CcSEcCtD
Ketoconazole—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.000116	0.00154	CcSEcCtD
Ketoconazole—Discomfort—Temozolomide—skin cancer	0.000115	0.00153	CcSEcCtD
Ketoconazole—Decreased appetite—Bleomycin—skin cancer	0.000115	0.00153	CcSEcCtD
Ketoconazole—Dry mouth—Temozolomide—skin cancer	0.000114	0.00151	CcSEcCtD
Ketoconazole—Jaundice—Docetaxel—skin cancer	0.000113	0.00151	CcSEcCtD
Ketoconazole—Pain—Bleomycin—skin cancer	0.000113	0.0015	CcSEcCtD
Ketoconazole—Leukopenia—Fluorouracil—skin cancer	0.000113	0.0015	CcSEcCtD
Ketoconazole—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000112	0.00149	CcSEcCtD
Ketoconazole—CYP2B6—lymphoid tissue—skin cancer	0.000112	0.00766	CbGeAlD
Ketoconazole—Anaphylactic shock—Temozolomide—skin cancer	0.000112	0.00148	CcSEcCtD
Ketoconazole—CYP1A1—female reproductive system—skin cancer	0.000111	0.0076	CbGeAlD
Ketoconazole—Nausea—Imiquimod—skin cancer	0.000111	0.00147	CcSEcCtD
Ketoconazole—Hepatobiliary disease—Docetaxel—skin cancer	0.00011	0.00146	CcSEcCtD
Ketoconazole—Epistaxis—Docetaxel—skin cancer	0.00011	0.00146	CcSEcCtD
Ketoconazole—Nervous system disorder—Temozolomide—skin cancer	0.000109	0.00145	CcSEcCtD
Ketoconazole—Thrombocytopenia—Temozolomide—skin cancer	0.000109	0.00145	CcSEcCtD
Ketoconazole—Feeling abnormal—Bleomycin—skin cancer	0.000109	0.00145	CcSEcCtD
Ketoconazole—Skin disorder—Temozolomide—skin cancer	0.000108	0.00144	CcSEcCtD
Ketoconazole—CYP2B6—female reproductive system—skin cancer	0.000108	0.00739	CbGeAlD
Ketoconazole—Myalgia—Fluorouracil—skin cancer	0.000107	0.00142	CcSEcCtD
Ketoconazole—Decreased appetite—Dactinomycin—skin cancer	0.000107	0.00142	CcSEcCtD
Ketoconazole—CYP2C9—female reproductive system—skin cancer	0.000107	0.00732	CbGeAlD
Ketoconazole—Fatigue—Dactinomycin—skin cancer	0.000106	0.00141	CcSEcCtD
Ketoconazole—Anorexia—Temozolomide—skin cancer	0.000106	0.00141	CcSEcCtD
Ketoconazole—Discomfort—Fluorouracil—skin cancer	0.000106	0.00141	CcSEcCtD
Ketoconazole—Pain—Dactinomycin—skin cancer	0.000106	0.0014	CcSEcCtD
Ketoconazole—Urticaria—Bleomycin—skin cancer	0.000105	0.0014	CcSEcCtD
Ketoconazole—Body temperature increased—Bleomycin—skin cancer	0.000105	0.00139	CcSEcCtD
Ketoconazole—Hepatitis—Docetaxel—skin cancer	0.000105	0.00139	CcSEcCtD
Ketoconazole—Oedema peripheral—Docetaxel—skin cancer	0.000103	0.00137	CcSEcCtD
Ketoconazole—Anaphylactic shock—Fluorouracil—skin cancer	0.000103	0.00137	CcSEcCtD
Ketoconazole—Connective tissue disorder—Docetaxel—skin cancer	0.000103	0.00136	CcSEcCtD
Ketoconazole—Feeling abnormal—Dactinomycin—skin cancer	0.000102	0.00135	CcSEcCtD
Ketoconazole—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000102	0.00135	CcSEcCtD
Ketoconazole—Insomnia—Temozolomide—skin cancer	0.000101	0.00134	CcSEcCtD
Ketoconazole—Gastrointestinal pain—Dactinomycin—skin cancer	0.000101	0.00134	CcSEcCtD
Ketoconazole—Nervous system disorder—Fluorouracil—skin cancer	0.000101	0.00134	CcSEcCtD
Ketoconazole—Thrombocytopenia—Fluorouracil—skin cancer	0.000101	0.00134	CcSEcCtD
Ketoconazole—Paraesthesia—Temozolomide—skin cancer	0.0001	0.00133	CcSEcCtD
Ketoconazole—Somnolence—Temozolomide—skin cancer	9.93e-05	0.00132	CcSEcCtD
Ketoconazole—Erythema multiforme—Docetaxel—skin cancer	9.88e-05	0.00131	CcSEcCtD
Ketoconazole—CYP19A1—lymph node—skin cancer	9.87e-05	0.00673	CbGeAlD
Ketoconazole—Dyspepsia—Temozolomide—skin cancer	9.83e-05	0.0013	CcSEcCtD
Ketoconazole—Anorexia—Fluorouracil—skin cancer	9.81e-05	0.0013	CcSEcCtD
Ketoconazole—Eye disorder—Docetaxel—skin cancer	9.77e-05	0.0013	CcSEcCtD
Ketoconazole—Abdominal pain—Dactinomycin—skin cancer	9.76e-05	0.0013	CcSEcCtD
Ketoconazole—Body temperature increased—Dactinomycin—skin cancer	9.76e-05	0.0013	CcSEcCtD
Ketoconazole—Hypersensitivity—Bleomycin—skin cancer	9.75e-05	0.00129	CcSEcCtD
Ketoconazole—Decreased appetite—Temozolomide—skin cancer	9.71e-05	0.00129	CcSEcCtD
Ketoconazole—Gastrointestinal disorder—Temozolomide—skin cancer	9.64e-05	0.00128	CcSEcCtD
Ketoconazole—Fatigue—Temozolomide—skin cancer	9.63e-05	0.00128	CcSEcCtD
Ketoconazole—Pain—Temozolomide—skin cancer	9.55e-05	0.00127	CcSEcCtD
Ketoconazole—Constipation—Temozolomide—skin cancer	9.55e-05	0.00127	CcSEcCtD
Ketoconazole—Asthenia—Bleomycin—skin cancer	9.5e-05	0.00126	CcSEcCtD
Ketoconazole—Angiopathy—Docetaxel—skin cancer	9.48e-05	0.00126	CcSEcCtD
Ketoconazole—Immune system disorder—Docetaxel—skin cancer	9.44e-05	0.00125	CcSEcCtD
Ketoconazole—Mediastinal disorder—Docetaxel—skin cancer	9.42e-05	0.00125	CcSEcCtD
Ketoconazole—Chills—Docetaxel—skin cancer	9.38e-05	0.00124	CcSEcCtD
Ketoconazole—Musculoskeletal discomfort—Fluorouracil—skin cancer	9.37e-05	0.00124	CcSEcCtD
Ketoconazole—Pruritus—Bleomycin—skin cancer	9.36e-05	0.00124	CcSEcCtD
Ketoconazole—Arrhythmia—Docetaxel—skin cancer	9.34e-05	0.00124	CcSEcCtD
Ketoconazole—CYP1A1—head—skin cancer	9.31e-05	0.00635	CbGeAlD
Ketoconazole—Insomnia—Fluorouracil—skin cancer	9.3e-05	0.00124	CcSEcCtD
Ketoconazole—Paraesthesia—Fluorouracil—skin cancer	9.24e-05	0.00123	CcSEcCtD
Ketoconazole—Alopecia—Docetaxel—skin cancer	9.23e-05	0.00123	CcSEcCtD
Ketoconazole—CYP1B1—lymph node—skin cancer	9.23e-05	0.00629	CbGeAlD
Ketoconazole—Feeling abnormal—Temozolomide—skin cancer	9.2e-05	0.00122	CcSEcCtD
Ketoconazole—Mental disorder—Docetaxel—skin cancer	9.16e-05	0.00122	CcSEcCtD
Ketoconazole—Somnolence—Fluorouracil—skin cancer	9.14e-05	0.00121	CcSEcCtD
Ketoconazole—Gastrointestinal pain—Temozolomide—skin cancer	9.13e-05	0.00121	CcSEcCtD
Ketoconazole—Erythema—Docetaxel—skin cancer	9.1e-05	0.00121	CcSEcCtD
Ketoconazole—Malnutrition—Docetaxel—skin cancer	9.1e-05	0.00121	CcSEcCtD
Ketoconazole—Hypersensitivity—Dactinomycin—skin cancer	9.09e-05	0.00121	CcSEcCtD
Ketoconazole—Dyspepsia—Fluorouracil—skin cancer	9.05e-05	0.0012	CcSEcCtD
Ketoconazole—CYP2B6—head—skin cancer	9.05e-05	0.00617	CbGeAlD
Ketoconazole—Decreased appetite—Fluorouracil—skin cancer	8.94e-05	0.00119	CcSEcCtD
Ketoconazole—Dysgeusia—Docetaxel—skin cancer	8.91e-05	0.00118	CcSEcCtD
Ketoconazole—Gastrointestinal disorder—Fluorouracil—skin cancer	8.88e-05	0.00118	CcSEcCtD
Ketoconazole—Urticaria—Temozolomide—skin cancer	8.87e-05	0.00118	CcSEcCtD
Ketoconazole—Asthenia—Dactinomycin—skin cancer	8.86e-05	0.00118	CcSEcCtD
Ketoconazole—Body temperature increased—Temozolomide—skin cancer	8.83e-05	0.00117	CcSEcCtD
Ketoconazole—Abdominal pain—Temozolomide—skin cancer	8.83e-05	0.00117	CcSEcCtD
Ketoconazole—Pain—Fluorouracil—skin cancer	8.8e-05	0.00117	CcSEcCtD
Ketoconazole—AR—lymph node—skin cancer	8.74e-05	0.00596	CbGeAlD
Ketoconazole—Feeling abnormal—Fluorouracil—skin cancer	8.48e-05	0.00113	CcSEcCtD
Ketoconazole—Diarrhoea—Dactinomycin—skin cancer	8.45e-05	0.00112	CcSEcCtD
Ketoconazole—Vomiting—Bleomycin—skin cancer	8.42e-05	0.00112	CcSEcCtD
Ketoconazole—Rash—Bleomycin—skin cancer	8.34e-05	0.00111	CcSEcCtD
Ketoconazole—Dermatitis—Bleomycin—skin cancer	8.34e-05	0.00111	CcSEcCtD
Ketoconazole—Hypersensitivity—Temozolomide—skin cancer	8.23e-05	0.00109	CcSEcCtD
Ketoconazole—CYP3A4—female reproductive system—skin cancer	8.18e-05	0.00558	CbGeAlD
Ketoconazole—Urticaria—Fluorouracil—skin cancer	8.17e-05	0.00108	CcSEcCtD
Ketoconazole—Leukopenia—Docetaxel—skin cancer	8.14e-05	0.00108	CcSEcCtD
Ketoconazole—Body temperature increased—Fluorouracil—skin cancer	8.13e-05	0.00108	CcSEcCtD
Ketoconazole—CYP2D6—female reproductive system—skin cancer	8.05e-05	0.00549	CbGeAlD
Ketoconazole—Asthenia—Temozolomide—skin cancer	8.01e-05	0.00106	CcSEcCtD
Ketoconazole—Pruritus—Temozolomide—skin cancer	7.9e-05	0.00105	CcSEcCtD
Ketoconazole—Nausea—Bleomycin—skin cancer	7.86e-05	0.00104	CcSEcCtD
Ketoconazole—Vomiting—Dactinomycin—skin cancer	7.85e-05	0.00104	CcSEcCtD
Ketoconazole—ABCB1—epithelium—skin cancer	7.8e-05	0.00532	CbGeAlD
Ketoconazole—Rash—Dactinomycin—skin cancer	7.78e-05	0.00103	CcSEcCtD
Ketoconazole—Arthralgia—Docetaxel—skin cancer	7.74e-05	0.00103	CcSEcCtD
Ketoconazole—Myalgia—Docetaxel—skin cancer	7.74e-05	0.00103	CcSEcCtD
Ketoconazole—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	7.69e-05	0.00102	CcSEcCtD
Ketoconazole—Diarrhoea—Temozolomide—skin cancer	7.64e-05	0.00101	CcSEcCtD
Ketoconazole—Hypersensitivity—Fluorouracil—skin cancer	7.58e-05	0.00101	CcSEcCtD
Ketoconazole—Dry mouth—Docetaxel—skin cancer	7.57e-05	0.00101	CcSEcCtD
Ketoconazole—Anaphylactic shock—Docetaxel—skin cancer	7.42e-05	0.000986	CcSEcCtD
Ketoconazole—Dizziness—Temozolomide—skin cancer	7.38e-05	0.00098	CcSEcCtD
Ketoconazole—Nausea—Dactinomycin—skin cancer	7.33e-05	0.000973	CcSEcCtD
Ketoconazole—Nervous system disorder—Docetaxel—skin cancer	7.28e-05	0.000967	CcSEcCtD
Ketoconazole—Pruritus—Fluorouracil—skin cancer	7.28e-05	0.000966	CcSEcCtD
Ketoconazole—Thrombocytopenia—Docetaxel—skin cancer	7.27e-05	0.000965	CcSEcCtD
Ketoconazole—Skin disorder—Docetaxel—skin cancer	7.21e-05	0.000957	CcSEcCtD
Ketoconazole—Vomiting—Temozolomide—skin cancer	7.1e-05	0.000942	CcSEcCtD
Ketoconazole—Anorexia—Docetaxel—skin cancer	7.08e-05	0.00094	CcSEcCtD
Ketoconazole—Rash—Temozolomide—skin cancer	7.04e-05	0.000935	CcSEcCtD
Ketoconazole—Diarrhoea—Fluorouracil—skin cancer	7.04e-05	0.000934	CcSEcCtD
Ketoconazole—Dermatitis—Temozolomide—skin cancer	7.03e-05	0.000934	CcSEcCtD
Ketoconazole—Headache—Temozolomide—skin cancer	6.99e-05	0.000929	CcSEcCtD
Ketoconazole—Dizziness—Fluorouracil—skin cancer	6.8e-05	0.000903	CcSEcCtD
Ketoconazole—Musculoskeletal discomfort—Docetaxel—skin cancer	6.76e-05	0.000898	CcSEcCtD
Ketoconazole—ABCB1—mammalian vulva—skin cancer	6.76e-05	0.00461	CbGeAlD
Ketoconazole—CYP2D6—head—skin cancer	6.73e-05	0.00459	CbGeAlD
Ketoconazole—Insomnia—Docetaxel—skin cancer	6.72e-05	0.000892	CcSEcCtD
Ketoconazole—Paraesthesia—Docetaxel—skin cancer	6.67e-05	0.000885	CcSEcCtD
Ketoconazole—Nausea—Temozolomide—skin cancer	6.63e-05	0.00088	CcSEcCtD
Ketoconazole—Somnolence—Docetaxel—skin cancer	6.6e-05	0.000876	CcSEcCtD
Ketoconazole—Vomiting—Fluorouracil—skin cancer	6.54e-05	0.000868	CcSEcCtD
Ketoconazole—Dyspepsia—Docetaxel—skin cancer	6.54e-05	0.000868	CcSEcCtD
Ketoconazole—CYP1A1—lymph node—skin cancer	6.52e-05	0.00445	CbGeAlD
Ketoconazole—Rash—Fluorouracil—skin cancer	6.49e-05	0.000861	CcSEcCtD
Ketoconazole—Dermatitis—Fluorouracil—skin cancer	6.48e-05	0.00086	CcSEcCtD
Ketoconazole—Decreased appetite—Docetaxel—skin cancer	6.45e-05	0.000857	CcSEcCtD
Ketoconazole—Headache—Fluorouracil—skin cancer	6.44e-05	0.000856	CcSEcCtD
Ketoconazole—Gastrointestinal disorder—Docetaxel—skin cancer	6.41e-05	0.000851	CcSEcCtD
Ketoconazole—Fatigue—Docetaxel—skin cancer	6.4e-05	0.00085	CcSEcCtD
Ketoconazole—Constipation—Docetaxel—skin cancer	6.35e-05	0.000843	CcSEcCtD
Ketoconazole—Pain—Docetaxel—skin cancer	6.35e-05	0.000843	CcSEcCtD
Ketoconazole—Feeling abnormal—Docetaxel—skin cancer	6.12e-05	0.000812	CcSEcCtD
Ketoconazole—Nausea—Fluorouracil—skin cancer	6.11e-05	0.000811	CcSEcCtD
Ketoconazole—Gastrointestinal pain—Docetaxel—skin cancer	6.07e-05	0.000806	CcSEcCtD
Ketoconazole—ABCB1—lymphoid tissue—skin cancer	6e-05	0.00409	CbGeAlD
Ketoconazole—Body temperature increased—Docetaxel—skin cancer	5.87e-05	0.000779	CcSEcCtD
Ketoconazole—Abdominal pain—Docetaxel—skin cancer	5.87e-05	0.000779	CcSEcCtD
Ketoconazole—ABCB1—female reproductive system—skin cancer	5.79e-05	0.00395	CbGeAlD
Ketoconazole—Hypersensitivity—Docetaxel—skin cancer	5.47e-05	0.000726	CcSEcCtD
Ketoconazole—Asthenia—Docetaxel—skin cancer	5.33e-05	0.000707	CcSEcCtD
Ketoconazole—Pruritus—Docetaxel—skin cancer	5.25e-05	0.000697	CcSEcCtD
Ketoconazole—Diarrhoea—Docetaxel—skin cancer	5.08e-05	0.000674	CcSEcCtD
Ketoconazole—Dizziness—Docetaxel—skin cancer	4.91e-05	0.000652	CcSEcCtD
Ketoconazole—ABCB1—head—skin cancer	4.84e-05	0.0033	CbGeAlD
Ketoconazole—Vomiting—Docetaxel—skin cancer	4.72e-05	0.000627	CcSEcCtD
Ketoconazole—Rash—Docetaxel—skin cancer	4.68e-05	0.000622	CcSEcCtD
Ketoconazole—Dermatitis—Docetaxel—skin cancer	4.68e-05	0.000621	CcSEcCtD
Ketoconazole—Headache—Docetaxel—skin cancer	4.65e-05	0.000618	CcSEcCtD
Ketoconazole—Nausea—Docetaxel—skin cancer	4.41e-05	0.000585	CcSEcCtD
Ketoconazole—ABCB1—lymph node—skin cancer	3.39e-05	0.00231	CbGeAlD
